John M. Berge

1.2k citations

29 papers · 977 · h-index 18

Impact in

Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity
- Asymmetric Synthesis and Catalysis
Microbiology top 10%

Papers in

Molecular Biology 20
- RNA and protein synthesis mechanisms 11
- Receptor Mechanisms and Signaling 5
- RNA modifications and cancer 4
- Genomics and Phylogenetic Studies 3
Organic Chemistry 12
- Synthetic Organic Chemistry Methods 4

Co-authors: Richard L. Jarvest (11 shared papers)Russell J. Cox (2 shared papers)Helen Chapman (5 shared papers)Dougal J. Ritson (2 shared papers)Paul Young (4 shared papers)Michael A. Cawthorne (2 shared papers)Stanley M. Roberts (3 shared papers)Peter J. O’Hanlon (9 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Bioorganic & Medicinal Chemistry (3 papers)Synlett (2 papers)Journal of the Chemical Society Perkin Transactions 1 (2 papers)The Journal of Antibiotics (1 paper)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

John M. Berge

26 papers receiving 938 citations

Peers

Countries citing papers authored by John M. Berge

Since Specialization

Citations

This map shows the geographic impact of John M. Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Berge more than expected).

Fields of papers citing papers by John M. Berge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Berge. The network helps show where John M. Berge may publish in the future.

Co-authors

The 25 scholars most cited alongside John M. Berge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John M. Berge Line = papers co-authored together John M. Berge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Crystal structure of Staphylococcus aureus tyrosyl‐tRNA synthetase in complex with a class of potent and specific inhibitors Protein Science ·Xiayang Qiu, Cheryl A. Janson, Ward W. Smith, Susan M. Green, Patrick McDevitt, Kyung Johanson, Paul Carter, Martin Hibbs, Ceri Lewis, Alison F. Chalker, Andrew Fosberry, Judith M. LaLonde, John M. Berge, Pamela Brown, C. S. V. HOUGE‐FRYDRYCH, Richard L. Jarvest	2001	166
2	Room temperature palladium catalysed coupling of acyl chlorides with terminal alkynes Chemical Communications ·Russell J. Cox, Dougal J. Ritson, Thomas A. Dane, John M. Berge, J.P.H. Charmant, A. Kantacha	2005	116
3	Novel α2-adrenoceptor antagonists show selectivity for α2A- and α2B-adrenoceptor subtypes European Journal of Pharmacology ·Paul Young, John M. Berge, Helen Chapman, Michael A. Cawthorne	1989	101
4	Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens Journal of Medicinal Chemistry ·Richard L. Jarvest, John M. Berge, Valerie Berry, Helen Boyd, Murray J. B. Brown, John S. Elder, Andrew K. Forrest, Andrew Fosberry, Daniel R. Gentry, Martin Hibbs, Deborah D. Jaworski, Peter J. O’Hanlon, Andrew J. Pope, Stephen Rittenhouse, Robert J. Sheppard, Courtney Slater-Radosti, Angela Worby	2002	92
5	Recommended Work-up Procedure for Reductions Employing Tri-n-butyltin Hydride Synthesis ·John M. Berge, Stanley M. Roberts	1979	54
6	The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. PubMed ·Matthew V. Sennitt, Alberto J. Kaumann, Peter Molenaar, Lee J. Beeley, Paul Young, John Kelly, Helen Chapman, Siân M. Henson, John M. Berge, David K. Dean, Nikesh R. Kotecha, Helen K.A. Morgan, Harshad K. Rami, Robert W. Ward, Mervyn Thompson, Shelagh Wilson, Stephen A. Smith, Michael A. Cawthorne, Michael J. Stock, Jonathan R.S. Arch	1998	53
7	Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, Sula A Armstrong, John M. Berge, Pamela Brown, John S. Elder, Murray J. B. Brown, Royston C. B. Copley, Andrew K. Forrest, Dieter Hamprecht, Peter J. O’Hanlon, Darren J. Mitchell, Stephen Rittenhouse, David R. Witty	2004	44
8	Fluorescence Polarization Method To Characterize Macrolide-Ribosome Interactions Antimicrobial Agents and Chemotherapy ·Kang Yan, Eric Hunt, John M. Berge, Earl W. May, Robert A. Copeland, Richard R. Gontarek	2005	36
9	Indium mediated allylation of glyoxylate oxime ethers, esters and cyanoformates Organic & Biomolecular Chemistry ·Dougal J. Ritson, Russell J. Cox, John M. Berge	2004	35
10	Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Murray J. B. Brown, Pamela Brown, John S. Elder, Andrew K. Forrest, C. S. V. HOUGE‐FRYDRYCH, Peter J. O’Hanlon, David McNair, Stephen Rittenhouse, Robert J. Sheppard	2003	32
11	Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of four stereoisomeric analogues of the natural product SB-219383 Bioorganic & Medicinal Chemistry Letters ·John M. Berge, Royston C. B. Copley, Drake S. Eggleston, Dieter Hamprecht, Richard L. Jarvest, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2000	28
12	4″-O-(ω-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens Bioorganic & Medicinal Chemistry ·Andrea Fajdetić, Hana Čipčić Paljetak, Gorjana Lazarevski, Antun Hutinec, Sulejman Alihodžić, Marko Đerek, Vlado Štimac, Daniele Andreotti, Vitomir Šunjić, John M. Berge, Stjepan Mutak, Miljenko Dumić, Sergio Lociuro, David Holmes, Nataša Maršić, Vesna Eraković Haber, Radan Spaventi	2010	26
13	Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity Bioorganic & Medicinal Chemistry ·Samra Kapić, Hana Čipčić Paljetak, Ivana Palej Jakopović, Andrea Fajdetić, Marina Ilijaš, Vlado Štimac, Karmen Brajša, David Holmes, John M. Berge, Sulejman Alihodžić	2011	25
14	The Contribution of Classical (β1/2-) and Atypical β-Adrenoceptors to the Stimulation of Human White Adipocyte Lipolysis and Right Atrial Appendage Contraction by Novel β3-Adrenoceptor Agonists of Differing Selectivities Journal of Pharmacology and Experimental Therapeutics ·Matthew V. Sennitt, Alberto J. Kaumann, Peter Molenaar, Lee J. Beeley, Paul Young, John Kelly, Helen Chapman, Siân M. Henson, John M. Berge, David K. Dean, Nikesh R. Kotecha, Helen K.A. Morgan, Harshad K. Rami, Robert W. Ward, Mervyn Thompson, Shelagh Wilson, Stephen A. Smith, Michael A. Cawthorne, Michael J. Stock, Jonathan R.S. Arch	1998	23
15	Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-Positive antibacterial activity Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Pamela Brown, C. S. V. HOUGE‐FRYDRYCH, Peter J. O’Hanlon, David McNair, Andrew J. Pope, Stephen Rittenhouse	2003	22
16	A diastereoselective synthesis of benzopyrans using a novel intramolecular Nicholas reaction in the key cyclisation step Tetrahedron Letters ·John M. Berge, Stephen Claridge, Alastair Mann, Christophe Müller, Elizabeth Tyrrell	1997	22
17	Synthesis and Activity of Analogues of SB-219383. Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase. The Journal of Antibiotics ·John M. Berge, N. J. P. BROOM, C. S. V. HOUGE‐FRYDRYCH, Richard L. Jarvest, Lucy Mensah, David McNair, Peter J. O’Hanlon, Andrew J. Pope, Stephen Rittenhouse	2000	20
18	Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383 Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, Pamela Brown, Dieter Hamprecht, David McNair, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2001	18
19	Addition of Vinylketenes to Enamines. A Method for the Preparation of 6,6‐Dialkylcyclohexa‐2,4‐dienones and 4,4‐Dialkyl‐2‐vinylcyclobutenones Helvetica Chimica Acta ·John M. Berge, Max Rey, Aǹdré S. Dreiding	1982	13
20	Inhibitors of Bacterial Tyrosyl tRNA Synthetase: Synthesis of Carbocyclic Analogues of the Natural Product SB-219383 Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest, John M. Berge, C. S. V. HOUGE‐FRYDRYCH, Lucy Mensah, Peter J. O’Hanlon, Andrew J. Pope	2001	10

About John M. Berge

John M. Berge is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 29 papers that have together received 977 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (11 papers), Microbial Natural Products and Biosynthesis (5 papers), Receptor Mechanisms and Signaling (5 papers), Synthetic Organic Chemistry Methods (4 papers), RNA modifications and cancer (4 papers), Bacterial Genetics and Biotechnology (3 papers), Genomics and Phylogenetic Studies (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Organic Chemistry (418 citations), Microbiology (55 citations), Molecular Biology (543 citations), Molecular Medicine (39 citations) and Cellular and Molecular Neuroscience (97 citations). John M. Berge has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Richard L. Jarvest, Russell J. Cox, Helen Chapman, Dougal J. Ritson, Paul Young, Michael A. Cawthorne, Stanley M. Roberts, Peter J. O’Hanlon, Pamela Brown and C. S. V. HOUGE‐FRYDRYCH. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Synlett, Journal of the Chemical Society Perkin Transactions 1 and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

John M. Berge

Impact in

Papers in i

In The Last Decade

John M. Berge

Peers

Countries citing papers authored by John M. Berge

Fields of papers citing papers by John M. Berge

All Works

About John M. Berge

Explore authors with similar magnitude of impact

Papers in